Become a Partner
Strategic Collaborations


QuiaPEG’s releasable PEGylation technology provides innovative and patentable opportunities to modify and improve drug properties, and is applicable to several stages of drug development, e.g.:

  • Enabling druggability of biomolecules with promising biological effects but challenging pharmacological properties
  • Creating improved versions of already approved drugs, as biobetters
  • Pro-drug development to extend market exclusivity, i.e. life cycle management

QuiaPEG offers licenses to companies interested in evaluating reversible PEGylation for their own drug development projects. We are also interested in discussing potential partnering opportunities regarding our in-house development projects.

Become a QuiaPEG partner 

QuiaPEG offers out-licensing and partnering opportunities.

Explore the opportunity to significantly improve the safety, efficacy and frequency of dosing pharmaceuticals. A partnership with QuiaPEG is built on a tailor-made agreement that furthers the overall objectives of both parties. If you are interested in learning more, please contact us at:

QuiaPEG Pharmaceuticals Holding AB

Virdings Allé 32 B
754 54 Uppsala
+46 (0) 70 693 12 53

User terms & privacy policy
Send a message